Assessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: An observational cohort study

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Vaughan Williams, Charles H ^a,f   Raman, Jaishree ^b   Raswiswi, Eric ^a   Immelman, Etienne ^c   Reichel, Holger ^d   Gate, Kelly ^e   Knight, Steve ^f  

^a Umkhanyakude Health District Office   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c Manguzi Hospital   (South Africa)

^d Mosvold Hospital   (South Africa)

^e Bethesda Hospital   (South Africa)

^f UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Artemether; KwaZulu Natal; Lumefantrine; Plasmodium falciparum malaria; Resistance markers; Therapeutic efficacy

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; CHLOROQUINE;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; GENE; HUMAN; MALARIA FALCIPARUM; MALE; MULTIDRUG RESISTANT 1 GENE; NONHUMAN; PFCRT GENE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD; SOUTH AFRICA;

ADOLESCENT; ADULT; AGED; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DRUG COMBINATIONS; DRUG RESISTANCE; ETHANOLAMINES; FEMALE; FLUORENES; GENE DOSAGE; GENES, PROTOZOAN; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; SOUTH AFRICA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84872309412     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-434     Document Type: Article

References (45)

1. World Health Organization, Methods for surveillance of antimalarial efficacy Geneva: WHO Press 2009
2. World Health Organization, World Malaria Report 2011 Geneva: WHO Press 2011
3. Impact of delayed introduction of sulphadoxine-pyrimethamine and arthemeter-lumefantrine on malaria epidemiology in KwaZulu-Natal. South Africa. Knight SE, Anyachebelu EJ, Geddes R, Maharaj R, Trop Med Int Health 2009 14 1086 1092 10.1111/j.1365-3156.2009.02333.x 19624481
4. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal. South Africa. Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, Allen E, Dlamini SS, Tsoka J, Bredenkamp B, Mthembu DJ, White NJ, Sharp BL, PLoS Med 2005 2 330 10.1371/journal.pmed.0020330 16187798 (Pubitemid 41735780)
5. Success of insecticide spraying in controlling malaria. Vaughan Williams CH, S Afr Med J 2003 93 160 12768931 (Pubitemid 36519618)
6. In vitro chloroquine-resistant Plasmodium falciparum malaria in the Natal/Kwazulu area. Herbst JM, Taylor LA, Joubert SM, S Afr Med J 1985 68 749 750 3904037 (Pubitemid 16211378)
7. In vitro confirmation of chloroquine-resistant Plasmodium falciparum malaria in KwaZulu. Freese JA, Sharp BL, Nxongo SN, Markus MB, S Afr Med J 1988 74 576 578 3057656 (Pubitemid 19031667)
8. Failure of sulphadoxine-pyrimethamine in treating Plasmodium falciparum malaria in KwaZulu-Natal. Bredenkamp BL, Sharp BL, Mthembu SD, Durrheim DN, Barnes KI, S Afr Med J 2001 91 970 972 11847918 (Pubitemid 34041119)
9. Malaria in South Africa-the past, the present and selected implications for the future. Sharp BL, le Sueur D, S Afr Med J 1996 86 83 89 8685790
10. KZN MCP Malaria Cases for Years 1996-2004 [ http://www.kznhealth.gov.za/ malaria1.pdf ]
11. Antimalarial drug resistance and combination chemotherapy. White N, Philos Trans R Soc Lond B Biol Sci 1999 354 739 749 10.1098/rstb.1999.0426 10365399 (Pubitemid 29365622)
12. World Health Organization, Guidelines for the treatment of Malaria-2nd edition Geneva: WHO Press 2010
13. Audit of failure rate of Coartem™ at single fourteen-day follow-up. Vaughan Williams CH, La Cock C, Henry GFJ, Ross AJ, SA Fam Pract 2002 25 8 12
14. Audit of efficacy of Coartem™ to clear Plasmodium falciparum malaria parasitaemia at single forty-two day follow-up. Vaughan Williams CH, La Cock C, Bredenkamp BLF, SA Fam Pract 2004 46 21 24
15. Novatis Pharma AG, Novartis International Package Leaflet Coartem Basel: Switzerland: Novartis Pharma AG 2012
16. Understanding the pharmacokinetics of Coartem. Djimde A, Lefevre G, Malar J 2009 8 1 4 10.1186/1475-2875-8-S1-S4 19917074
17. Clinical pharmacokinetics and pharmacodynamics of artemether- lumefantrine. White NJ, van Vugt M, Ezzet F, Clin Pharmacokinet 1999 37 105 125 10.2165/00003088-199937020-00002 10496300 (Pubitemid 29431479)
18. The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria. Borrmann S, Sallas WM, Machevo S, Gonzalez R, Bjorkman A, Martensson A, Hamel M, Juma E, Peshu J, Ogutu B, Djimde A, D'Alessandro U, Marrast AC, Lefevre G, Kern SE, Trop Med Int Health 2010 15 434 441 20180933
19. Steady state pharmacokinetics of mefloquine in long-term travellers. Pennie RA, Koren G, Crevoisier C, Trans R Soc Trop Med Hyg 1993 87 459 462 10.1016/0035-9203(93)90036-P 8249080
20. Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria. Hung T-Y, Davis TME, Ilett KF, Karunajeewa H, Hewitt S, Denis MB, Lim C, Socheat D, Br J Clin Pharmacol 2003 57 253 262 10.1046/j.1365-2125.2003.02004.x
21. The assessment of antimalarial drug efficacy. White NJ, Trends Parasitol 2002 18 458 464 10.1016/S1471-4922(02)02373-5 12377597
22. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
23. Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast. Borrmann S, Sasi P, Mwai L, Bashraheil M, Abdallah A, Muriithi S, Fruhauf H, Schaub B, Pfeil J, Peshu J, Hanpithakpong W, Rippert A, Juma E, Tsofa B, Mosobo M, Lowe B, Osier F, Fegan G, Lindegardh N, Nzila A, Peshu N, Mackinnon M, Marsh K, PLoS One 2011 6 26005 10.1371/journal.pone.0026005 22102856
24. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Roper C, Pearce R, Bredenkamp B, Gumede J, Drakeley C, Mosha F, Chandramohan D, Sharp B, Lancet 2003 361 1174 1181 10.1016/S0140-6736(03)12951-0 12686039 (Pubitemid 36398386)
25. Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out. Raman J, Mauff K, Muianga P, Mussa A, Maharaj R, Barnes KI, PLoS One 2011 6 25992 10.1371/journal.pone.0025992 22022487
26. World Health Organization, Monitoring antimalarial drug resistance Geneva: World Health Organization 2002
27. A molecular marker for chloroquine-resistant falciparum malaria. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Coulibaly D, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, N Engl J Med 2001 344 257 263 10.1056/NEJM200101253440403 11172152 (Pubitemid 32108530)
28. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Price RN, Uhlemann AC, van Vugt M, Brockman A, Hutagalung R, Nair S, Nash D, Singhasivanon P, Anderson TJ, Krishna S, White NJ, Nosten F, Clin Infect Dis 2006 42 1570 1577 10.1086/503423 16652314
29. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). Sisowath C, Stromberg J, Martensson A, Msellem M, Obondo C, Bjorkman A, Gil JP, J Infect Dis 2005 191 1014 1017 10.1086/427997 15717281 (Pubitemid 40349821)
30. Coartem (artemether-lumefantrine) in Africa: the beginning of the end? Hastings IM, Ward SA, J Infect Dis 2005 192 1303 1304 author reply 1304-1305 10.1086/432554 16136476 (Pubitemid 41368433)
31. The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. Sisowath C, Ferreira PE, Bustamante LY, Dahlstrom S, Martensson A, Bjorkman A, Krishna S, Gil JP, Trop Med Int Health 2007 12 736 742 10.1111/j.1365-3156.2007.01843.x 17550470 (Pubitemid 46872790)
32. World Health Organization, Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission Geneva: World Health Organization 1996
33. Rapid diagnostic tests for malaria parasites. Moody A, Clin Microbiol Rev 2002 15 66 78 10.1128/CMR.15.1.66-78.2002 11781267 (Pubitemid 34052582)
34. DGM Microbiology working group, Standard Operating Procedure: Processing specimens for Malaria parasites Johannesburg: South African National Health Laboratory Service 2011
35. Real-time PCR for detection and identification of Plasmodium spp. Mangold KA, Manson RU, Koay ES, Stephens L, Regner M, Thomson RB Jr, Peterson LR, Kaul KL, J Clin Microbiol 2005 43 2435 2440 10.1128/JCM.43.5.2435-2440.2005 15872277 (Pubitemid 40656261)
36. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, Do Rosario VE, Thaithong S, Brown KN, Mol Biochem Parasitol 1993 61 315 320 10.1016/0166-6851(93)90077-B 8264734
37. Chloroquine-resistant Plasmodium falciparum infections among UK travellers returning with malaria after chloroquine prophylaxis. Sutherland CJ, Haustein T, Gadalla N, Armstrong M, Doherty JF, Chiodini PL, J Antimicrob Chemother 2007 59 1197 1199 10.1093/jac/dkm104 17475629 (Pubitemid 47073334)
38. Department of Health Republic of South Africa, Guidelines for the treatment of malaria in South Africa Pretoria: Department of Health 2008
39. Association between the pfmdr1 gene and in vitro artemether and lumefantrine sensitivity in Thai isolates of Plasmodium falciparum. Mungthin M, Khositnithikul R, Sitthichot N, Suwandittakul N, Wattanaveeradej V, Ward SA, Na-Bangchang K, AmJTrop Med Hyg 2010 83 1005 1009 10.4269/ajtmh.2010.10-0339
40. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. Kublin JG, Cortese JF, Njunju EM, Mukadam RA, Wirima JJ, Kazembe PN, Djimde AA, Kouriba B, Taylor TE, Plowe CV, J Infect Dis 2003 187 1870 1875 10.1086/375419 12792863 (Pubitemid 36724485)
41. Detection and species determination of malaria parasites by PCR: comparison with microscopy and with ParaSight-F and ICT malaria Pf tests in a clinical environment. Tham JM, Lee SH, Tan TM, Ting RC, Kara UA, J Clin Microbiol 1999 37 1269 1273 10203469 (Pubitemid 29187782)
42. Pilot assessment of the sensitivity of the malaria thin film. Ohrt C, O'Meara WP, Remich S, McEvoy P, Ogutu B, Mtalib R, Odera JS, Malar J 2008 7 22 10.1186/1475-2875-7-22 18226243 (Pubitemid 351389089)
43. Comparison of the diagnosis of malaria by microscopy, immunochromatography and PCR in endemic areas of Venezuela. Rodulfo H, De Donato M, Mora R, Gonzalez L, Contreras CE, Braz J Med Biol Res 2007 40 535 543 17401497 (Pubitemid 46605027)
44. The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Maude RJ, Pontavornpinyo W, Saralamba S, Aguas R, Yeung S, Dondorp AM, Day NP, White NJ, White LJ, Malar J 2009 8 31 10.1186/1475-2875-8-31 19228438
45. Fight Malaria: Africa Goes from Control to Elimination by 2010. African Union, African Union Launch of the Africa Malaria Elimination Campaign during 3rd Session of AU Conference of Ministers of Health Johannesburg, South Africa 2007